CDC Website CDC Website

To Join the NPIN community or

Home » Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)

Innovative Epidemiologic Approaches for Understanding Long-term Health Outcomes of HIV-exposed Uninfected (HEU) Populations (R61/R33 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to encourage the use of a phased research approach to generate information needed to develop interventions to reduce long-term effects of in utero exposure to antiretroviral therapy (ART) and/or HIV on health outcomes. This FOA will support two-phased research applications to (1) demonstrate the capacity to enroll sufficient numbers of HIV-exposed uninfected (HEU) infants, children, adolescents, and/or young adults in the United States and/or international settings with high HIV burden, and then, to (2) utilize the established cohort with innovative epidemiological approaches to conduct research. 

Letter of Intent Date
11/2/19
Application Due Date
12/2/19
Project Start Date
7/1/20
Application Contact
Bryan
Clark, MBA
Chief Grants Management Officer
United States
301-432-6975
clarkb1@mail.nih.gov
Technical Contact
Sonia
Lee, PhD
Program Officer
LeeSonia@mail.nih.gov
United States
301-594-4783
Fund Duration
The scope of the proposed project should determine the project period. The maximum project period for an application submitted in response to this FOA cannot exceed five years.
Subjects
Audiences

Fund Number: 

5503

Fund ID: 

RFA-HD-20-008

Last modified: 

9/18/19